Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435273
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-05-24
Brief Title:
A Randomised Double-blind Parallel Group Placebo Controlled 4-Week Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma
Sponsor:
Organization:
AstraZeneca